
CASE DISCUSSION
Care gap in Cancer Treatment in India
Presented from India by Dr. G. V. Nagarjuna Reddy0
Likes
1463
Views
59
Shares
59
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
The care gap in cancer treatment in India is significant, characterized by disparities in access to early diagnosis and advanced therapies. Rural areas face a severe shortage of oncology specialists and diagnostic facilities, leading to delayed treatment and poorer outcomes. High costs of cancer...
Case Summary
- India faces a significant cancer burden, with estimates suggesting approximately 14.6 lakh new cases in 2022 and projections indicating a doubling by 2030 or 2040. The incidence rate is approximately 100.4 per lakh population, highlighting a concerning prevalence. Non-communicable diseases, including cancer, contribute significantly to mortality, driven largely by alcohol and tobacco use, followed by physical inactivity and other factors.
Speaker Profile

Dr. G. V. Nagarjuna Reddy
Head & Neck Oncosurgeon, Ex-Tata Memorial Hospitals, Mumbai.Dr. G V Nagarjuna Reddy, a distinguished Consultant Head and Neck Surgical Oncologist, completed his MBBS from KMC and M.S. ENT from PGIMER Chandigarh. With a wealth of experience and expertise, he has served as a Senior Resident at Tata Memorial Hospital Mumbai and pursued fellowships in Head and Neck Surgical Oncology with prestigious institutions such as IFHNOS (International Federation of Head and Neck Oncologic Societies), RCS (London), and HCG Hospital Bangalore. Dr. Reddy's specialization includes the diagnosis and treatment of various head and neck conditions, encompassing benign lesions like thyroglossal cysts, submandibular stones, and branchial cysts, as well as complex cases such as nerve sheath tumors, head and neck cancers, laryngectomy, voice prosthesis, thyroid swellings, parotid swellings and cancers, and nasal bleeding and cancers. His extensive training and dedication to advancing surgical oncology make him a valuable asset in the field of head and neck oncology.